Early Initiation of Enzyme Replacement Therapy in Infantile Onset Pompe Disease Improves Cardiac Outcomes: A Longitudinal Analysis

Documenti analoghi

• Efficacy of Switching Therapy From Alglucosidase Alfa to Avalglucosidase Alfa on Respiratory Function in Participants With Late‐Onset Pompe Disease: A Post Hoc Analysis From the COMET Trial
  di: Priya S. Kishnani, et al.
  Pubblicazione: (2025)
• Elevated Transaminases: Does It Always Warrant a Liver Biopsy? Lessons Learned From Pompe Disease
  di: Alicia Khazzeka, et al.
  Pubblicazione: (2025)
• Correction to “Farber's Lipogranulomatosis: Multimodal Therapy With Tocilizumab and Consolidative HSCT Improves Assessment, and Long‐Term Outcome”
  Pubblicazione: (2025)
• A Mild Juvenile Onset Canavan Disease With Atypical Clinical Presentation and MRI Brain Features
  di: Preeya Rehsi, et al.
  Pubblicazione: (2025)
• Biochemical, Clinical, and Functional Characterization of a Rare c.‐ 106C >A Promoter Region Variant in Late‐Onset Ornithine Transcarbamylase Deficiency: A Multifamily Case Series
  di: Samuel Quinn Tholl, et al.
  Pubblicazione: (2026)